Investors Bag BTAI 7.4% Lower Than Its Secondary Stock Offering
September 23, 2021 at 11:33 AM EDT
Looking back to 92 days ago, BioXcel Therapeutics Inc (BTAI) priced a 3,155,000 share secondary stock offering at $31.70 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..